Mission
Dyadic uses its proprietary technology to discover and develop novel genes and other biological products from eukaryotic organisms found in the full spectrum of the earth’s biodiversity.

Once useful genes are isolated, Dyadic uses its integrated platform to manufacture specific proteins, doing so more rapidly and efficiently – and with a much higher rate of success – than existing gene discovery systems are capable of.

Strategy
Dyadic leverages its proprietary technology platform to discover novel genes and biological products for use by its strategic partners, and to further the company’s own R&D efforts.

Dyadic seeks strategic alliances with major leaders in the agricultural, biological, industrial, chemical and biopharmaceutical industries that have in-house genomic capabilities. Dyadic will also collaborate with companies whose genomic capabilities are limited, discovering and expressing biological materials for these strategic partners.

In addition, Dyadic, using these proprietary systems, will continue to commercialize enzymes for use in targeted markets including the animal nutrition, detergent, ethanol, pulp and paper, biopharmaceutical, starch, and textile industries.

Dyadic expects to generate significant revenue from its direct product sales, as well as from profit sharing through joint ventures and collaborations. Additionally, revenue will be generated through research and development funding and milestone and royalty payments from Dyadic's strategic partners.